Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Qualitative Evaluation of Perceived Effects Elicited by AEF0217 in Individuals With Down Syndrome

NCT07413224 is registered in ClinicalTrials.gov with Aelis Farma as lead sponsor.

NCT NCT07413224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07413224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Qualitative Evaluation of Perceived Effects Elicited by AEF0217 in Individuals With Down Syndrome
Lead sponsor
Aelis Farma
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 1, 2026
Completion date
May 31, 2026
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome (trisomy 21)